沃华医药
(002107)
| 流通市值：41.77亿 | | | 总市值：42.19亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 219,045,381.55 | 816,952,424.84 | 624,613,354.3 | 425,358,485.78 |
| 营业收入 | 219,045,381.55 | 816,952,424.84 | 624,613,354.3 | 425,358,485.78 |
| 二、营业总成本 | 177,276,991.23 | 721,298,250.06 | 562,597,697.56 | 383,615,906.86 |
| 营业成本 | 48,268,449.66 | 201,114,648.37 | 155,377,134.44 | 109,473,266.18 |
| 税金及附加 | 3,817,327.3 | 14,347,228.55 | 11,028,929.36 | 7,272,990.07 |
| 销售费用 | 100,433,506.95 | 407,251,977.03 | 322,344,401.75 | 214,620,640.12 |
| 管理费用 | 16,931,758.39 | 66,129,923.71 | 49,538,847.83 | 34,110,587.74 |
| 研发费用 | 8,014,142.01 | 36,394,805.27 | 27,223,461.28 | 20,317,040.72 |
| 财务费用 | -188,193.08 | -3,940,332.87 | -2,915,077.1 | -2,178,617.97 |
| 其中:利息费用 | 10,042.82 | 62,306.1 | 51,101.52 | 36,330.2 |
| 其中:利息收入 | 210,969.29 | 4,042,283.59 | 2,982,741.76 | 2,225,057.59 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | 1,763,146.58 | 820,176.99 | 820,176.99 |
| 资产减值损失(新) | 27,283.79 | -1,950,661.77 | -1,759,310.49 | -1,545,569.11 |
| 信用减值损失(新) | 616,524.77 | 3,113,190.19 | 4,269,743.43 | 4,087,598.58 |
| 其他收益 | 1,110,481.55 | 5,018,194.16 | 3,186,795.99 | 2,085,452.2 |
| 四、营业利润 | 43,522,680.43 | 103,598,043.94 | 68,533,062.66 | 47,190,237.58 |
| 加:营业外收入 | 389,712.07 | 494,594.69 | 227,689.3 | 109,973.15 |
| 减:营业外支出 | 20,827.32 | 1,713,065.74 | 276,252.61 | 273,876.55 |
| 五、利润总额 | 43,891,565.18 | 102,379,572.89 | 68,484,499.35 | 47,026,334.18 |
| 减:所得税费用 | 5,440,686.82 | 13,588,501.27 | 9,513,883.03 | 5,848,669.96 |
| 六、净利润 | 38,450,878.36 | 88,791,071.62 | 58,970,616.32 | 41,177,664.22 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 38,450,878.36 | 88,931,033.05 | 59,110,577.75 | 41,317,625.65 |
| 终止经营净利润 | - | -139,961.43 | -139,961.43 | -139,961.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 36,648,737.04 | 95,715,292.65 | 63,994,992.35 | 44,676,392.95 |
| 少数股东损益 | 1,802,141.32 | -6,924,221.03 | -5,024,376.03 | -3,498,728.73 |
| 扣除非经常损益后的净利润 | 35,743,706.1 | 92,106,702.57 | 61,271,092.16 | 42,735,464.72 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.17 | 0.11 | 0.08 |
| (二)稀释每股收益 | 0.06 | 0.17 | 0.11 | 0.08 |
| 九、综合收益总额 | 38,450,878.36 | 88,791,071.62 | 58,970,616.32 | 41,177,664.22 |
| 归属于母公司股东的综合收益总额 | 36,648,737.04 | 95,715,292.65 | 63,994,992.35 | 44,676,392.95 |
| 归属于少数股东的综合收益总额 | 1,802,141.32 | -6,924,221.03 | -5,024,376.03 | -3,498,728.73 |
| 公告日期 | 2026-04-08 | 2026-01-20 | 2025-10-18 | 2025-07-22 |
| 审计意见(境内) | | 标准无保留意见 | | |